Skip to content
Open access

A loss-of-function mutation in the GTPase domain of MFN2, perverting mitochondrial dynamics, is associated with dilated cardiomyopathy

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

Functional analysis in stable H9c2 cardiomyoblast cell lines demonstrated significantly reduced MFN2 mutant protein expression, extensive mitochondrial clustering and fragmentation, suggesting a significant correlation with the pathogenesis of DCM.

Read PDF

Similar papers

Open access Jul 2026

The SMYD1 p.Asn101Ser is a partial loss-of-function variant that impairs mitochondrial function and leads to early-onset cardiomyopathy

The first functional characterization of the cardiomyopathy-associated SMYD1 N101S variant identified in a child with severe infantile cardiomyopathy is provided, establishing a mechanistic link between SMYD1 dysfunction and infantile cardiomyopathy and highlighting the importance of integrating genomic and functional...

Marta W. Szulik, Clint Gwynn, Magnus Creed et al. · 0 citations
Aug 2026

The identification of drp1 patient mutations that limit interactions with mff.

Patient mutations within Drp1, the master regulator of mitochondrial fission, lead to severe neurological defects and poor patient outcomes. Many of these mutations have been characterized as causing functional or assembly defects in Drp1, but our study highlights three mutations (G362S, E379K, E410K) that do not have...

Yuli Buckley, Anelise N. Hutson, Brianna L. Bauer et al. · 0 citations
Open access Aug 2026

Characterization of the frameshift c.515dupC knock-in mouse model of HSPB8-associated myopathy (MFM13) and evaluation of Trehalose as autophagy-modulating therapy

These findings support the value of preclinical models for translational studies, and autophagy enhancement as a potential therapeutic strategy for HSPB8-related myopathy, and evaluated trehalose, a natural disaccharide that induces HSPB8 and enhances autophagy.

Alyaa Shmara, Lan Weiss, A. Gromova et al. · 0 citations
Case report Open access Jan 2026

Expanding the Recessive Spectrum of Dilated Cardiomyopathy: RNA‐Level Validation of a Homozygous CTNNA3 Splice‐Site Variant

Evidence is provided that biallelic CTNNA3 splice‐disrupting variants can cause human cardiomyopathy driven by ICD dysfunction, and the dissociation between ventricular recovery and persistent arrhythmia highlights the complex phenotypic spectrum of CTNNA3‐related disease.

Stefania Martino, Mara Doimo, M. Iacoviello et al. · 0 citations
Open access Aug 2026

Preliminary functional characterization of the LMNA c.929 A > G (p.Gln310Arg) variant identified in a patient with dilated cardiomyopathy

Preliminary variant-specific functional evidence is provided but do not establish the pathogenicity of the variant or the causal relationships among the observed cellular abnormalities, and further validation in endogenous and physiologically relevant cardac models is required.

Zi-Kang Han, Yong-Hao Sheng, Hanice Sun et al. · 0 citations
Open access Jul 2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson’s disease (ARPD)

These findings establish a mechanistic link between mutation-induced structural dynamics and impaired PINK1–ubiquitin recognition at Ser65, providing a mutation-specific framework for understanding early mitophagy impairment in ARPD and supporting future molecular assessment and targeted therapeutic development.

Deborah Vincent, C. Sudandiradoss · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.